Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» KTE-C19
KTE-C19
3 Top-Performing Biotech Stocks This Week
Motley Fool
Fri, 06/16/17 - 09:51 am
biotech
Kite Pharma
KTE-C19
Bluebird Bio
CAR-T
Lexicon Pharmaceuticals
With Kite’s PDUFA date looming, federal court tosses Juno’s CAR-T patent challenge — for now
Endpoints
Wed, 06/14/17 - 11:43 am
Kite Pharma
PDUFA
CAR-T
patents
Juno Therapeutics
KTE-C19
One of Kite Pharma’s CAR-T patients died from cerebral edema, triggering a safety alarm
Endpoints
Mon, 05/8/17 - 11:33 am
Kite Pharma
CAR-T
cerebral edema
KTE-C19
Juno Therapeutics
Kite Pharma hits its Q1 deadline on filing a BLA for its pioneering CAR-T, posts improved data
Endpoints
Fri, 03/31/17 - 10:06 pm
Kite Pharma
CAR-T
KTE-C19
non-Hodgkin's lymphoma
Kite Hits 52-Week High on Positive Study
Investopedia
Wed, 03/1/17 - 11:30 am
Kite Pharma
KTE-C19
non-Hodgkin's lymphoma
Kite Pharma reports positive results from non-Hodgkins lymphoma drug study
Marketwatch
Tue, 02/28/17 - 11:08 am
Kite Pharma
non-Hodgkins lymphoma
KTE-C19
CAR-T
3 Drugs Heading to the FDA Soon
Motley Fool
Mon, 12/12/16 - 09:34 am
FDA
Kite Pharma
KTE-C19
Flexion
Zilretta
AG-221
Agios Pharmaceuticals
Celgene
3 Big Advances In Cancer Treatment In 2016
Motley Fool
Mon, 12/12/16 - 09:24 am
cancer
Merck
Keytruda
Kite Pharma
KTE-C19
Ariad Pharmaceuticals
brigatinib
Novartis Makes Its Case For Driving A CAR Into The Real World
Seeking Alpha
Mon, 12/5/16 - 10:43 pm
Novartis
CAR-T
Kite Pharma
CTL019
KTE-C19
Kite adds promising leukemia responses in small CAR-T studies, then fires the starting gun on its rolling submission
Endpoints
Mon, 12/5/16 - 10:01 am
Kite Pharma
CAR-T
clinical trials
KTE-C19
acute lymphoblastic leukemia
Kite Pharma Is Ready To Soar
Seeking Alpha
Fri, 11/25/16 - 09:16 am
Kite Pharma
KTE-C19
Kite Pharma to keep anticipated CAR-T launch 'controlled' and targeted at certain hospitals
Medical Marketing and Media
Wed, 11/16/16 - 09:59 am
Kite Pharma
CAR-T
KTE-C19
diffuse large B-cell lymphoma
Kite Pharma Details KTE-C19 Launch Preparedness and Near-Term, Next Generation CAR/TCR Product Candidates at Investor Day
Yahoo
Thu, 10/20/16 - 09:17 am
Kite Pharma
KTE-C19
CAR-T
non-Hodgkin's lymphoma
Following Kite Pharma's Positive Top-Line Data, Focus Turns To Commercial Outlook
Yahoo/Benzinga
Sat, 10/8/16 - 03:46 pm
Kite Pharma
clinical trials
KTE-C19
CAR-T
refractory lymphoma
Kite Pharma Claims CAR-T Trial Victory, FDA Filing Next
TheStreet.com
Tue, 09/27/16 - 09:56 am
Kite Pharma
CAR-T
FDA
KTE-C19
diffuse large B-cell lymphoma
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
Kite Pharma opens cell therapy plant as lead CAR-T candidate gathers steam
BioPharma Dive
Tue, 06/21/16 - 11:17 pm
Kite Pharma
CAR-T
KTE-C19
3 Biotechs Expecting Market-Moving Trial Results Soon
Motley Fool
Mon, 06/6/16 - 11:07 am
biotech
Ophthotech
Achillion
Kite Pharma
odalasvir
JNJ
Fovista
KTE-C19
Kite Pharma Announces Review of National Cancer Institute’s Manufacturing Facilities
Yahoo
Sun, 04/17/16 - 10:42 am
Kite Pharma
National Cancer Institute
KTE-C19
clinical trials
Roche, Kite Pharma sign CAR-T and PD-L1 combo deal
Fierce Biotech
Fri, 03/18/16 - 11:00 am
Roche
Kite Pharma
CAR-T
PD-L1
atezolizumab
KTE-C19
Pages
1
2
next ›
last »